Contact
Search
Sign in
Home
Publications
Annals of Long-Term Care
First Report Managed Care
Integrated Healthcare Executive
Pharmacy Learning Network
Veterans Health Today
EventsEducationAbout
-
About
-
Education
-
Resources
-
Conference Coverage
-
Topics
-
Talking Therapeutics
-
Job Board
-
About
-
Education
-
Resources
-
Conference Coverage
-
Topics
-
Talking Therapeutics
-
Job Board
Advertisem*nt
Advertisem*nt
');zE(function() { zE('webWidget', 'hide');});});jQuery('.backdrop').on('click', function() {alert('test'); jQuery('.backdrop').hide(); zE('webWidget', 'hide');});function help_show() {jQuery('.backdrop').show();zE('webWidget', 'show');zE('webWidget', 'open');zE('webWidget:on', 'close', function() { jQuery('.backdrop').hide(); zE('webWidget', 'hide');});}
Advertisem*nt
ADVERTIsem*nT
News
Jolynn Tumolo
03/03/2022
Perrigo Company is recalling nasal sprays distributed by various retailers throughout the United States after learning they were manufactured using a contaminated excipient that was recalled by the excipient’s supplier. The recalls were included in the March 2, 2022, US Food and Drug Administration (FDA) Enforcement Report.
The recalls were voluntarily initiated by the firm October 26, 2021, and were designated Class II by the FDA on February 23, 2022. The classification communicates that use of the recalled products may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
The recall includes the following products:
- Maximum Strength Plus Menthol No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 72288-703-10), from batches 1FK1251 (Exp. 2/28/23) and 1BK0716 (Exp. 12/31/22), distributed by Amazon.com Services;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 50594-719-10), from batch 1BK0827 (Exp. 12/31/22), packaged by Perrigo Company for Big Lots Stores Inc;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 41520-108-10), from batches 1BK0716 (Exp. 12/31/22) and 1FK1251 (Exp. 2/28/23), distributed by Foodhold USA;
- Severe Congestion No-Drip Nasal Spray Plus Menthol, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 55910-511-10), from batches 1BK0716 (Exp. 12/31/22), 1CK0899 (Exp. 1/31/23), and 1FK1163 (Exp. 1/31/23), distributed by Dolgencorp;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl 0.05%, 1 fl oz (30 mL) per bottle (NDC 11822-6378-1), from batch 11BK0827 (Exp. 12/31/22), distributed by Rite Aid;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl 0.05%, 1 fl oz (30 mL) per bottle (NDC 21130-813-10), from batches 1BK0716 (Exp. 12/31/22), and 1FK1251 and 1HK1196 (Exp. 2/28/23), distributed by Better Living Brands;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 41163-343-10), from batch 1FK1251 (Exp. 2/28/23), distributed by SuperValu Inc.;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 11673-935-10), from batches 1BK0912 (Exp. 12/31/22), 1FK1251 (Exp. 2/28/23), distributed by Target Corp;
- Severe Congestion Nasal Spray, No-Drip Plus Menthol, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 36800-907-10), from batch 1BK0716 (Exp. 12/31/22), distributed by Topco Associates;
- Maximum Strength No-Drip Nasal Spray, oxymetazoline hcl 0.05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 72288-388-10), from batch 1BK0964R (Exp. 1/31/23), distributed by Amazon.com Services;
- Maximum Strength No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 72288-388-10), from batches 1BK0826 (Exp 12/31/22) and 1BK0964R (Exp. 1/31/23), distributed by Amazon.com Services;
- No-Drip Nasal Mist, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 59779-388-10), from batch 1FK1164 (Exp. 1/31/23), distributed by CVS Pharmacy Inc;
- Maximum Strength No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 55910-623-10), from batches 1BK0826 (Exp. 12/31/22), and 1FK1232 and 1BK0964 (Exp. 1/31/23), distributed by Old East Main Co;
- Nasal Spray Decongestant, No-Drip, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 30142-388-10), from batch 1BK0826 (Exp. 12/31/22), distributed by Kroger Co;
- Soothing 12-Hour Nasal Decongestant Spray No-Drip, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 0904-6761-30), from batches 1BK0826 (Exp. 12/31/22) and 1FK1164 (Exp. 1/31/23), distributed by Major Pharmaceuticals;
- Maximum Strength No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 41250-388-10), from batch 1FK1164 (Exp. 1/31/23), distributed by Meijer Distribution, Inc;
- Maximum Strength No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 30142-388-10), from batch 1BK0826 (Exp 12/31/22), distributed by Kroger Co;
- Maximum Strength No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 11822-6319-1), from batches 1BK0964 (Exp. 1/31/23) and 1FK1164 (Exp. 1/31/23), distributed by Rite Aid;
- No-Drip Nasal Decongestant, oxymetazoline hcl .05%, 1 fl oz (30 mL) per bottle (NDC 21130-801-10), from batch 1BK0964 (Exp. 1/31/23), distributed by Better Living Brands;
- No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 41163-703-10), from batch 1BK0964 (Exp. 1/31/23), distributed by SuperValu Inc;
- No-Drip Nasal Spray, oxymetazoline hcl 0.05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 36800-388-10), from batch 1FK1233 (Exp. 1/31/23), distributed by Topco Associates;
- No-Drip Nasal Spray, oxymetazoline hcl .05% nasal decongestant, 1 fl oz (30 mL) per bottle (NDC 49035-388-10), from batches 1CK0897, 1FK1233, and 1FK1232 (Exp. 1/31/23), distributed by Walmart Inc;
- Sinus Severe, oxymetazoline hcl .05% nasal decongestant with menthol, 1 fl oz (30 mL) per bottle (NDC 55910-696-10), from batches 1BK0931 (Exp. 12/31/22), 1CK0900 (Exp. 1/31/23), and 1HK1196 (Exp. 2/28/23), distributed by Dolgencorp; and
- Maximum Strength Nasal Spray, oxymetazoline hcl .05% nasal decongestant with menthol, 1 fl oz (30 mL) per bottle (NDC 41250-989-10), from batch 1BK0716 (Exp. 12/31/22), distributed by Meijer Distribution Inc.
Advertisem*nt
Advertisem*nt
Stay Informed & Sign Up Today
Pharmacy Learning Network Newsletter
Advertisem*nt
Follow us on Twitter
Video Insights
Videos David Rubin, MD, on JAK Inhibitors: Small But Mighty 11/22/2023 Featuring David Rubin, MD Featuring David Rubin, MD Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease. Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease. Dr Rubin reviews his... 11/22/2023 Pharmacy Learning Network
Videos Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment 11/10/2023 FeaturingPaul Schulz, MD FeaturingPaul Schulz, MD Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD. Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD. Dr Shulz discusses the... 11/10/2023 Pharmacy Learning Network
Videos Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis 10/27/2023 Featuring Ronald Vender, MD, FRCPC Featuring Ronald Vender, MD, FRCPC ... In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis. In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis. In this exclusive interview, Dr... 10/27/2023 Pharmacy Learning Network
Videos Application of Dupilumab to Pediatric Patients With Atopic Dermatitis 10/27/2023 FeaturingAbigail Cline, MD, PhD, FAAD FeaturingAbigail Cline, MD, PhD, FAA... In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients. In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients. In this feature video, Dr... 10/27/2023 Pharmacy Learning Network
Videos Patient Considerations When Prescribing Lecanemab for Alzheimer Disease 10/06/2023 Featuring Paul Schulz, MD Featuring Paul Schulz, MD Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD. Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD. Dr Paul Schulz discusses the... 10/06/2023 Pharmacy Learning Network
Videos Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More 07/18/2023 FeaturingChris Fausel, PharmD, MHA, BCOP;Erin Hamai Tom, PharmD, APh, MBA, BCACP; andRyan Nix, PharmD, MMHC FeaturingChris Fausel, PharmD, MHA, ... In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting. In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting. In this roundtable, cochairs of... 07/18/2023 Pharmacy Learning Network
Videos Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments 06/28/2021 Julie Gould Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in... Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in... Chris Fausel, PharmD, Val Adams,... 06/28/2021 Pharmacy Learning Network
Videos Expanded FDA Approval Improves Care Access, Rates of Flu Cases 04/19/2021 Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means... Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means... Gregg Sylvester, MD, MPH, chief... 04/19/2021 Pharmacy Learning Network
Videos Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems 12/28/2020 Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion. Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion. Tom Knight, founder and CEO,... 12/28/2020 Pharmacy Learning Network
Videos Identifying Risks of Human Error, Workarounds in Pharmacy 12/22/2020 Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and... Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and... Matthew Grissinger, RPh, FISMP,... 12/22/2020 Pharmacy Learning Network
Advertisem*nt
Advertisem*nt
Specialties
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Gastroenterology
Infectious Diseases
Neurology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Pulmonology
Surgery
Urology
Wound Care
Events
- HMP Event Calendar
Year Round Education
-
Live Events
HMP Global Products
-
About
-
Sign in
- Contact
Advertisem*nt
Advertisem*nt
